IL10 and familial pancreatic carcinoma: They discovered that suppressing interleukin-10, an immune inhibitory cytokine secreted by Tregs and pancreatic cancer cells, can reverse the negative effect of the tumor microenvironment on mesothelin-CAR-T cells in pancreatic cancer in vitro [81].